Dolutegravir is one of the most potent antiviral drugs now being used in clinical practise to treat HIV. Scientists from the Salk Institute and the National Institutes of Health have discovered the molecular routes through which the human immunodeficiency virus (HIV) develops resistance to i
Researchers from the Salk Institute and the National Institutes of Health have identified the molecular pathways by which the human immunodeficiency virus (HIV) develops resistance to dolutegravir, one of the most potent antiviral medications now being used in clinical use to treat HIV.